Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
PYC THERAPEUTICS LIMITED (PYC)ASX AI Signals has generated 1 signal(s) for PYC during the last 90 days, indicating Moderate trading activity
Latest PYC Signals | |
| 19/06/2026 | BUY |
PYC Share Price | |
| Current Price | $1.535 |
| 52 Week High | $1.699 |
| 52 Week Low: | $0.830 |
| Trading at (% of 52 Week High) | 90.35% |
PYC Therapeutics Limited (ASX: PYC) is a biotechnology company that develops gene therapies for skin diseases. The company focuses on creating treatments for genetic skin conditions by using its proprietary topical delivery platform. Its goal is to provide non-invasive therapies that can improve patient outcomes.
The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.
The BUY signal for PYC Therapeutics Limited is supported by positive momentum and potential growth in the biotech sector, but the relatively low current price and market volatility introduce moderate risk.
The Australian market has been navigating a period of uncertainty, with key indices fluctuating due to geopolitical events and rising inflation, while sectors like materials have shown resilience amidst these challenges. In this environment, identifying high growth tech stocks requires focusing on c There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. Having said that, unprofitable companies are risky because To get a sense of who is truly in control of PYC Therapeutics Limited (ASX:PYC), it is important to understand the ownership structure of the business. With 50% stake, individual insiders possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But the harsh reality is that very many loss making companies burn t Every investor in PYC Therapeutics Limited (ASX:PYC) should be aware of the most powerful shareholder groups. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time. I quite like to see at least a little bit oLatest PYC THERAPEUTICS LIMITED(PYC) News
High Growth Tech Stocks in Australia for November 2025
Here's Why We're Watching PYC Therapeutics' (ASX:PYC) Cash Burn Situation
Owning 50% in PYC Therapeutics Limited (ASX:PYC) means that insiders are heavily invested in the company's future
Will PYC Therapeutics (ASX:PYC) Spend Its Cash Wisely?
Is PYC Therapeutics Limited (ASX:PYC) Popular Amongst Insiders?
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial